Hi Team,
The minutes and link to meeting recording for the June 30th meeting of
the *content sub-team* of the PDDI Info Model Task Force are pasted
below. Thanks to Elizabeth Garcia for writing them!
Kind regards, -R
Minutes for 6/30/2016 (Content subgroup)
In Attendance: Evan Draper, Sam Habiel, Richard Boyce, Dan Malone,
Elizabeth Garcia, Louisa Zhang
Meeting recording: http://goo.gl/1d7uwg
Meeting:
*
Progress on user-centered definitions
o
User-Centered Definitions
<https://docs.google.com/document/d/1MGPXSkRZVXCd8nzhEgHJLLSxYLhcixiNPqnAmty---M/edit?usp=sharing>(Google
Doc allows for further comments)
o
Formal definitions will be used to develop an computer-readable
ontology
o
Completed:
+
Clinical Consequences: discussion about beneficial
clinical consequence example; will be updated as per Evan’s
comments
+
Evidence: minor edits; will also need to add examples of
types of evidence described in definition
o
Direction moving forward:
+
Mechanism of Interaction
#
Qualtrics will be sent out ASAP
+
Frequency of Harm
#
Draft by the end of July
+
Middle of August: remaining definitions
#
i.e., contextual information/modifying factors,
recommended actions, seriousness rating
*
User Stories and Use Cases
o
Descriptions of the users who will be using this information model
o
Google Doc listing information needs has been developed; further
development into user stories
+
Draft document: PDDI User Information Needs
<https://docs.google.com/document/d/1EhHudBgH4TqNdqULZKJYp2tgyO2QtHANdbFSXH5rlUg/edit?usp=sharing>
o
Elizabeth and Louisa will be reaching out to task force members
for feedback on user stories
+
Elizabeth: clinicians
+
Louisa: clinical decision support
+
Will take 1-2 more weeks to get the Google Doc together;
will be updated by July 18th
o
Medication Reconciliation Use Cases
+
Elizabeth has interviewed a hospital pharmacist and will
interview a consultant pharmacist in order to develop 2-3
detailed use cases
+
Question about whether to useSuggested potential drug-drug
interactions
<https://docs.google.com/spreadsheets/d/1DIeIuo7tZ6nVvd6MdO2xzzLtOSPXjAHI-DdBe9M3kiw/edit#gid=716618333>for
use cases
#
Proposed adding linezolid + SSRI as a potential
drug-drug interaction, based on hospital pharmacist
discussion
*
Modifying factors are unknown; where you would give
this pair is set by the indications of the drugs
#
Added a new category: DDI where modifying factors are
not known
*
Very common in clinical practice
*
Decision Tree Development
o
Need to delegate the further development of decision trees for
the project
+
Remaining: DDI pairs that do not have highlights
o
We want something very similar to the decision trees we have in
place
+
Describe what the interaction is (fairly specifically)
+
What things would be helpful for a clinician to know?
o
Sub-group: Evan, Dan, John
+
Evan – Tyrosine kinase inhibitors + proton pump inhibitors,
Warfarin + etoposide
+
Dan – Tamoxifen + paroxetine, MAOIs + stimulants
+
Rich will discuss with John (to get 1 or 2 more done)
+
Doodle Poll will be sent out for sub-group meeting between
July 11thand July 22nd
o
Follow up at next Content meeting
*
Next Steps
o
Qualtrics: “Mechanism of Interaction” user-centered definition
will be sent out July 1
o
Decision Tree Sub-Group (Dan, John, Evan): Look out for Doodle
Poll (July 11 – July 22)
o
All-Team Meeting: Look out for Doodle Poll (July 25 – August 5)
o
Medication Reconciliation Use Cases (Elizabeth): draft will be
posted on Task Force website July 1
+
Further discussion at next All-Team Meeting
o
Next Content Sub-Team Meeting (July 19)
+
Agreeing on Drug Interactions to Focus on for Information
Model development
+
User Stories (Elizabeth and Louisa): Updated Google Doc by
July 18
